Eterna Therapeutics
ERNA
#10321
Rank
โ‚น0.93 B
Marketcap
โ‚น118.58
Share price
0.76%
Change (1 day)
-70.83%
Change (1 year)

Revenue for Eterna Therapeutics (ERNA)

Revenue in 2025 (TTM): โ‚น0.08 Million

According to Eterna Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚น0.08 Million. In 2024 the company made a revenue of โ‚น49.92 Million an increase over the revenue in the year 2023 that were of โ‚น5.66 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Eterna Therapeutics from 2020 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น0.08 M-99.83%
2024 โ‚น49.92 M781.97%
2023 โ‚น5.66 M
2022 N/A
2021 N/A
2020 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Baxter
BAX
โ‚น990.26 B 1,102,299,900.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
โ‚น16.47 B 18,340,200.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น4.269 T 4,752,507,999.60%๐Ÿ‡ซ๐Ÿ‡ท France
Bio-Techne
TECH
โ‚น109.30 B 121,673,000.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
โ‚น1.53 B 1,710,185.10%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
โ‚น1.507 T 1,677,599,900.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel